How Did SoftBank Achieve a $7.7 Billion Profit Surprise?

December 17, 2024

In a remarkable financial turnaround, Japan’s SoftBank Group reported a net profit of 1.18 trillion yen, or approximately $7.7 billion, for the quarter ending in September, significantly exceeding analysts’ expectations of 287 billion yen ($1.87 billion). The company managed to shift from a staggering loss of 931 billion yen during the same quarter last year, thanks in large part to the rising share prices of listed companies within SoftBank’s Vision Fund portfolios. This incredible recovery highlights the company’s resilient investment strategy and its capacity to adapt to changing market conditions.

SoftBank’s Vision Fund, which includes various high-growth tech startups, recorded an investment gain of 608 billion yen, marking profitability in four of the last five quarters. This positive outcome illustrates the effectiveness of SoftBank’s cautious approach toward investments, driven by past large losses resulting from interest rate hikes and decreased valuations of tech startups. According to Chief Financial Officer Yoshimitsu Goto, this conservative strategy has been instrumental in converting previous challenges into substantial profits. SoftBank’s optimism is buoyed by the anticipation of public listings for some of its portfolio companies, reinforcing the company’s long-term growth prospects.

Strategic Investment Shifts

The Vision Fund’s profitability was further bolstered by exiting investments worth $1.85 billion, including complete exits from notable entities such as Chinese AI firm SenseTime and Indian payment innovator PayTm. Despite a generally muted IPO market, SoftBank successfully monetized its holdings through strategic investment exits. The IPO of chip designer Arm in September 2023 served as a standout success, contributing significantly to the quarter’s gains. The notable performances of Chinese ride-hailing giant Didi and South Korean e-commerce firm Coupang also propelled Vision Fund 1’s investment gain to an impressive $2.76 billion.

Meanwhile, Vision Fund 2, which focuses on early-stage tech startups, recorded a more modest gain of 800 million yen for the same period. This disparity between Vision Fund 1 and Vision Fund 2 underscores the contrasting challenges and opportunities associated with investing in mature versus emerging companies. Additionally, SoftBank capitalized on a $2.5 billion investment gain from its stake in T-Mobile, highlighting its diversified investment strategy. By leveraging these different streams of revenue, SoftBank demonstrated its ability to navigate complex market dynamics effectively.

Financial Resurgence and Market Position

In an impressive financial rebound, Japan’s SoftBank Group reported a net profit of 1.18 trillion yen, or about $7.7 billion, for the quarter ending in September. This result far surpassed analysts’ expectations of 287 billion yen (approximately $1.87 billion). The company made a significant turnaround from the same quarter last year, when it suffered a massive loss of 931 billion yen. This recovery is largely attributed to the rising share prices of companies within SoftBank’s Vision Fund portfolios, showcasing the resilience of the company’s investment strategy.

The Vision Fund, which focuses on high-growth tech startups, achieved an investment gain of 608 billion yen and has been profitable in four of the last five quarters. This success underscores the effectiveness of SoftBank’s cautious investment approach shaped by previous large losses due to interest rate hikes and declining valuations of tech startups. Chief Financial Officer Yoshimitsu Goto noted that this conservative strategy has been key to turning past challenges into significant profits. SoftBank is optimistic about the public listings of some of its portfolio companies, boosting its long-term growth prospects.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later